Freenome, Inc. - Common stock (FRNM)

10.77
-0.61 (-5.36%)
NASDAQ· Last Trade: Jul 29th, 3:27 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close11.38
Open11.34
Bid10.55
Ask10.70
Day's Range10.37 - 11.76
52 Week Range10.37 - 14.26
Volume759,927
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume805,225

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026